Advanced search
Publication Cover
Hypertension in Pregnancy Volume 38, 2019 - Issue 3
Submit an article Journal homepage
302
Views
29
CrossRef citations to date
0
Altmetric
Articles

Placental sFLT1 is associated with complement activation and syncytiotrophoblast damage in preeclampsia

Ai-ris Yonekura CollierDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA;Department of Obstetrics and Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USACorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-8539-3960View further author information
ORCID Icon,
Zsuzsanna ZsengellerDepartment of Obstetrics and Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USA;Department of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information
,
Elizabeth PerniconeDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information
,
Saira SalahuddinDepartment of Obstetrics and Gynecology, Beth Israel Deaconess Medical Center, Boston, MA, USA;Department of Obstetrics and Gynecology and Reproductive Biology, Harvard Medical School, Boston, MA, USAView further author information
,
Eliyahu V. KhankinDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, USAView further author information
&
S. Ananth KarumanchiDepartment of Medicine, Division of Nephrology, Beth Israel Deaconess Medical Center, Boston, MA, USA;Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USAORCID Iconhttp://orcid.org/0000-0002-2281-6831View further author information
ORCID Icon
Pages 193-199 | Received 06 May 2019, Accepted 01 Jul 2019, Published online: 10 Jul 2019

References

  • Rana S, Lemoine E, Granger J, et al. Preeclampsia. Circ Res. 2019;124(7):1094–1112.
  • Kim MY, Guerra MM, Kaplowitz E, et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Ann Rheum Dis. 2018;77(4):549–555.
  • Walport MJ. Complement. First of two parts. N Engl J Med. 2001;344(14):1058–1066.
  • Walport MJ. Complement. Second of two parts. N Engl J Med. 2001;344(15):1140–1144.
  • Cohen D, Colvin RB, Daha MR, et al. Pros and cons for C4d as a biomarker. Kidney Int. 2012;81(7):628–639.
  • Girardi G, Bulla R, Salmon JE, et al. The complement system in the pathophysiology of pregnancy. Mol Immunol. 2006; 43(1-2): 68-77.
  • Lee J, Romero R, Xu Y, et al. A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS One. 2011 Feb 04;6(2):e16806.
  • Penning M, Chua JS, van Kooten C, et al. Classical complement pathway activation in the kidneys of women with preeclampsia. Hypertension. 2015;66(1):117–125.
  • He Y, Xu B, Song D, et al. Expression of the complement system’s activation factors in plasma of patients with early/late-onset severe pre-eclampsia. Am J Reprod Immunol. 2016 Sep;76(3):205–211.
  • Song D, Yu XJ, Wang FM, et al. Overactivation of complement alternative pathway in postpartum atypical hemolytic uremic syndrome patients with renal involvement. Am J Reprod Immunol. 2015;74(4):345–356.
  • Salmon JE, Heuser C, Triebwasser M, et al. Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med. 2011;8(3):e1001013.
  • Shamonki JM, Salmon JE, Hyjek E, et al. Excessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol. 2007 Feb;196(2):167e1–5.
  • Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355(10):992–1005.
  • Keir LS, Firth R, Aponik L, et al. VEGF regulates local inhibitory complement proteins in the eye and kidney. J Clin Invest. 2017;127(1):199–214.
  • American College of, Obstetricians, Gynecologists and Task Force on Hypertension in, Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ task force on hypertension in pregnancy. Obstet Gynecol. 2013;122(5):1122–1131.
  • Rajakumar A, Cerdeira AS, Rana S, et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension. 2012;59(2):256–264.
  • Wang A, Zsengeller ZK, Hecht JL, et al. Excess placental secreted frizzled-related protein 1 in maternal smokers impairs fetal growth. J Clin Invest. 2015;125(11):4021–4025.
  • Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
  • Venkatesha S, Toporsian M, Lam C, et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 2006;12(6):642–649.
  • Jebbink J, Keijser R, Veenboer G, et al. Expression of Placental FLT1 Transcript Variants Relates to. Hypertension. 2011;70–76.
  • Ashar-Patel A, Kaymaz Y, Rajukumar A, et al. FLT1 and transcriptome-wide polyadenylation site (PAS) analysis in preeclampsia. Sci Rep. 2017;7(1):12139.
  • Girardi G, Yarlin D, Thurman JM, et al. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203(9):2165–2175.
  • Banadakoppa M, Balakrishanan M, Yallampalli C. Upregulation and release of soluble fms-like tyrosine kinase receptor 1 mediated by complement activation in human syncytiotrophoblast cells. Am J Reprod Immunol. 2018;80(5):e13033.
  • Burwick RM, Feinberg BB. Eculizumab for the treatment of preeclampsia/HELLP syndrome. Placenta. 2013;34(2):201–203.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.